معرفی
Professor Andrew McLachlan is the Head of School and Dean of Pharmacy at the Sydney Pharmacy School, University of Sydney. He holds a BPharm(Hons1 Medal) and PhD, and is a Member of the Order of Australia (AM). His research focuses on clinical pharmacology, particularly optimizing medication use in special populations such as older adults, children, and critically ill patients. He has led initiatives like the NHMRC Centre for Research Excellence in Medicines and Ageing, and his work emphasizes translating clinical evidence into real-world practice.
Education:
- Bachelor of Pharmacy (First Class Honours)
- PhD in Clinical Pharmacology
Research Interests:
- Variability in drug response across populations
- Quality use of medicines in geriatrics
- Pharmacotherapy optimization in critical care
- Deprescribing strategies for older adults
Grants & Projects:
- PROSPER Trial (2025): Evaluating opioid alternatives for postoperative pain
- DREAM Trial (2024): Duloxetine for chronic sciatica
Awards:
- Member of the Order of Australia (AM)
Key Contributions:
- Leading deprescribing initiatives
- Advancing personalized pharmacotherapy
- Improving medication safety in vulnerable populations
۰مقاله منتشرشده
